KAMI HARRIS: Open Payments
NPI 1134625643 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,681 in 110 payments from 18 companies in 2025. Trend: 2023 $2,728 · 2024 $2,931 · 2025 $4,681
Food & beverage: $2,492Consulting: $1,500Travel & lodging: $677Education: $11
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $2,396 |
| Janssen Pharmaceuticals, Inc | 9 | $391 |
| Teva Pharmaceuticals USA, Inc. | 15 | $363 |
| Otsuka America Pharmaceutical, Inc. | 15 | $240 |
| ABBVIE INC. | 16 | $229 |
| Axsome Therapeutics, Inc. | 9 | $228 |
| Alkermes, Inc. | 12 | $213 |
| Vanda Pharmaceuticals Inc. | 4 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Indivior Inc. | 3 | $88 |
Products named: SPRAVATO, UZEDY, Auvelity, REXULTI, ARISTADA, VRAYLAR, FANAPT, INGREZZA.
Industry payments across NC — which companies pay providers there.
